help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 23, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0962
A more recent version of this article appeared on November 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/11/5928    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sikaris, K.
Right arrow Articles by Handelsman, D. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sikaris, K.
Right arrow Articles by Handelsman, D. J

Submitted on May 2, 2005
Accepted on August 12, 2005

REPRODUCTIVE HORMONE REFERENCE INTERVALS FOR HEALTHY FERTILE YOUNG MEN: EVALUATION OF AUTOMATED PLATFORM ASSAYS

Ken Sikaris, Robert I McLachlan, Rymantas Kazlauskas, David de Kretser, Carol A Holden, and David J Handelsman*

RCPA/AACB Chemical Pathology Quality Assurance Programs Pty Ltd, Flinders Medical Centre, Bedford Park, South Australia, Australia; Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia; Australian Sports Drug Testing Laboratory, National Measurement Institute, Pymble, NSW, Australia; Andrology Australia, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia; Department of Andrology, Concord Hospital, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia

* To whom correspondence should be addressed. E-mail: djh{at}anzac.edu.au.

Context. Management of male infertility and/or androgen deficiency requires accurate hormonal measurements with valid reference intervals.

Objective. To develop a valid reference panel of blood samples from healthy eugonadal young men with verified normal reproductive function. To use this panel to evaluate the performance of 7 fully automated commercial multiplex immunoassay platforms used to measure serum total testosterone (T), LH and FSH.

Design. Observational study of consistency between 7 different automated immunoassays for each of total T, LH and FSH. Each method was implemented in two laboratories each repeating the analysis of the full reference panel samples twice. Serum T concentration was also measured by gas chromatography/mass spectrometry (GC/MS) and serum inhibin B levels by an enzyme-linked immunosorbent assay.

Setting. Commercial, high volume clinical pathology laboratories

Participants. From 147 men screened, sera from 124 healthy reproductively normal men (age 21-35 yr) with normal sperm output was used as a reference panel. All laboratories selected for elite performance in the national immunoassay quality assurance program agreed to participate.

Main Outcome Measure(s). For each of 868 assays, descriptive statistics were calculated in the natural and log-transformed scales and analyzed by nested, repeated measures ANOVA after log-transformation. Reference intervals, defined as 95% confidence limits, were calculated using arithmetic (natural scale), geometric (log-scale) and non-parametric methods.

Results. Descriptive statistics and reference intervals for serum T, LH and FSH differed widely and significantly between methods but variation between laboratories for the same assay was negligible. All T method showed significant differences in regression slope and intercept in deviance plots as well as in estimated reference ranges compared with the independent GC/MS reference method. Although similar between-method differences existed for gonadotropin assays, the smaller quantitative discrepancies allowed assignment of consensus reference intervals for serum FSH (1.3-8.4 IU/L) and LH (1.6-8.0 IU/L) though these differed from manufacturers currently quoted expected values.

Conclusions. Using a reference panel of sera from healthy, eugonadal young men with verified normal reproductive function, major differences exist between commercial T immunoassays as well as divergence from the GC/MS standard. This impairs their clinical diagnostic utility and requires substantial improvements in automated T immunoassay technologies or a switch to GC/MS methods. Gonadotropin assays showed less variability but current high throughput immunoassays remain suboptimal to confirm accurate diagnosis of azoospermia or androgen deficiency.


Key words: testosterone • male reproductive hormones • LH • FSH • inhibin B • reference intervals




This article has been cited by other articles:


Home page
Hum ReprodHome page
D. Jamsai, A. Reilly, S.J. Smith, G.M. Gibbs, H.W.G. Baker, R.I. McLachlan, D.M. de Kretser, and M.K. O'Bryan
Polymorphisms in the human cysteine-rich secretory protein 2 (CRISP2) gene in Australian men
Hum. Reprod., June 10, 2008; (2008) den191v1.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. A. Boepple, F. J. Hayes, A. A. Dwyer, T. Raivio, H. Lee, W. F. Crowley Jr, and N. Pitteloud
Relative Roles of Inhibin B and Sex Steroids in the Negative Feedback Regulation of Follicle-Stimulating Hormone in Men across the Full Spectrum of Seminiferous Epithelium Function
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1809 - 1814.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Grossmann, M. C. Thomas, S. Panagiotopoulos, K. Sharpe, R. J. MacIsaac, S. Clarke, J. D. Zajac, and G. Jerums
Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1834 - 1840.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. S. Swerdloff and C. Wang
Free Testosterone Measurement by the Analog Displacement Direct Assay: Old Concerns and New Evidence
Clin. Chem., March 1, 2008; 54(3): 458 - 460.
[Full Text] [PDF]


Home page
PediatricsHome page
R. F. Greaves, R. W. Hunt, A. S. Chiriano, and M. R. Zacharin
Luteinizing Hormone and Follicle-Stimulating Hormone Levels in Extreme Prematurity: Development of Reference Intervals
Pediatrics, March 1, 2008; 121(3): e574 - e580.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. Meier, T. V. Nguyen, D. J. Handelsman, C. Schindler, M. M. Kushnir, A. L. Rockwood, A. W. Meikle, J. R. Center, J. A. Eisman, and M. J. Seibel
Endogenous Sex Hormones and Incident Fracture Risk in Older Men: The Dubbo Osteoporosis Epidemiology Study
Arch Intern Med, January 14, 2008; 168(1): 47 - 54.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Allan, B. J. G. Strauss, H. G. Burger, E. A. Forbes, and R. I. McLachlan
Testosterone Therapy Prevents Gain in Visceral Adipose Tissue and Loss of Skeletal Muscle in Nonobese Aging Men
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Roy, M. Alevizaki, and I. Huhtaniemi
In vitro bioassays for androgens and their diagnostic applications
Hum. Reprod. Update, January 1, 2008; 14(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. Aksglaede, J. H Petersen, K. M Main, N. E Skakkebaek, and A. Juul
High normal testosterone levels in infants with non-mosaic Klinefelter's syndrome
Eur. J. Endocrinol., September 1, 2007; 157(3): 345 - 350.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wang, P. Christenson, and R. Swerdloff
Clinical Relevance of Racial and Ethnic Differences in Sex Steroids
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2433 - 2435.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. B Yeap, O. P Almeida, Z. Hyde, P. E Norman, S A P. Chubb, K. Jamrozik, and L. Flicker
In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study
Eur. J. Endocrinol., May 1, 2007; 156(5): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. Rosner, R. J. Auchus, R. Azziz, P. M. Sluss, and H. Raff
Utility, Limitations, and Pitfalls in Measuring Testosterone: An Endocrine Society Position Statement
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 405 - 413.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R.I. McLachlan, E. Rajpert-De Meyts, C.E. Hoei-Hansen, D.M. de Kretser, and N.E. Skakkebaek
Histological evaluation of the human testis--approaches to optimizing the clinical value of the assessment: Mini Review
Hum. Reprod., January 1, 2007; 22(1): 2 - 16.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. J. Handelsman
The Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in Sport
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1646 - 1653.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society